Principal Securities, Inc. Biomarin Pharmaceutical Inc Transaction History
Principal Securities, Inc.
- $3.21 Trillion
- Q1 2024
A detailed history of Principal Securities, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Principal Securities, Inc. holds 1,647 shares of BMRN stock, worth $138,496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,647
Previous 1,704
3.35%
Holding current value
$138,496
Previous $164 Million
12.45%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
617Shares Held
182MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.57 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.52 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.22 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.18 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$580 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...